KRISTIN RYGG: Open Payments
NPI 1760634588 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$92,047 in 289 payments from 19 companies in 2025. Trend: 2023 $59,633 · 2024 $71,664 · 2025 $92,047
Consulting: $57,122Speaker / faculty: $20,795Travel & lodging: $7,404Food & beverage: $6,726
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 53 | $33,692 |
| Incyte Corporation | 50 | $14,329 |
| Galderma Laboratories, L.P. | 43 | $11,508 |
| Almirall LLC | 13 | $10,987 |
| GENZYME CORPORATION | 19 | $7,821 |
| Novartis Pharmaceuticals Corporation | 19 | $5,910 |
| PFIZER INC. | 5 | $3,211 |
| LEO Pharma Inc. | 13 | $2,059 |
| ABBVIE INC. | 29 | $669 |
| Janssen Biotech, Inc. | 9 | $452 |
Products named: Zoryve, OPZELURA, Klisyri, COSENTYX, NEMLUVIO, Seysara, AKLIEF, CIBINQO.
Industry payments across CO — which companies pay providers there.
